Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2017-12-01
2020-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Prefrontal Cortex Stimulation on Antisocial and Aggressive Behavior
NCT02427672
Investigating Transcranial Direct Current Stimulation (tDCS) in Accelerating Learning in a Healthy Older Population
NCT03467698
The Effect of Repeated Prefrontal Cortex Stimulation on Antisocial and Aggressive Behavior
NCT02674516
Stimulating the Brain to Improve Self-Awareness
NCT03370341
A Functional Magnetic Resonance Imaging Investigation of Transcranial Direct Current Stimulation
NCT03623815
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Transcranial Direct Current Stimulation (tDCS) is a form of noninvasive neurostimulation which has been proposed as a therapeutic procedure in numerous psychiatric conditions. TDCS therefore may be a promising therapeutic technique for reducing symptoms of psychosis, and specifically paranoia. This study will compare experiences of paranoid ideation in individuals who are high in sub-clinical paranoia across two conditions: active anodal tDCS and sham tDCS.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active anodal tDCS, Then Sham tDCS
Active anodal tDCS followed by behavioral testing; one week later, sham tDCS followed by behavioral testing
active anodal tDCS
active anodal tDCS with behavioral tasks and self-report measures to assess paranoid ideation
sham tDCS
sham tDCS with behavioral tasks and self-report measures to assess paranoid ideation
Sham tDCS, then Active anodal tDCS
Sham tDCS followed by behavioral testing; one week later, active anodal tDCS followed by behavioral testing.
active anodal tDCS
active anodal tDCS with behavioral tasks and self-report measures to assess paranoid ideation
sham tDCS
sham tDCS with behavioral tasks and self-report measures to assess paranoid ideation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
active anodal tDCS
active anodal tDCS with behavioral tasks and self-report measures to assess paranoid ideation
sham tDCS
sham tDCS with behavioral tasks and self-report measures to assess paranoid ideation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* previous classification as being high in sub-clinical paranoia
Exclusion Criteria
* use of psychotropic medication
* Presence or history of medical, cardiac, or neurological disorders that may affect brain function (e.g., cardiac disease, endocrine disorders, renal disease, pulmonary disease, history of seizures or head trauma with unconsciousness for a period of 15 minutes or greater or CNS tumors)
* Presence of sensory limitation including visual (e.g., blindness, glaucoma, vision uncorrectable to 20/40) or hearing (e.g. hearing loss) impairments that interfere with assessment
* Not proficient in English
* Contraindications for tDCS (e.g., pregnancy or implanted devices such as pace maker)
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas at Dallas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amy Pinkham, PhD
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amy Pinkham, PhD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas at Dallas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Unversity of Texas at Dallas
Richardson, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-126
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.